Journal Logo

Articles by Thomas Kahan

Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension

Kasiakogias, Alexandros; Rosei, Enrico Agabiti; Camafort, Miguel; More

Journal of Hypertension. 39(8):1522-1545, August 2021.

Blood pressure levels and risk of haemorrhagic stroke in patients with atrial fibrillation and oral anticoagulants: results from The Swedish Primary Care Cardiovascular Database of Skaraborg

Bager, Johan-Emil; Hjerpe, Per; Schiöler, Linus; More

Journal of Hypertension. 39(8):1670-1677, August 2021.

Nutraceuticals and blood pressure control: a European Society of Hypertension position document

Borghi, Claudio; Tsioufis, Konstantinos; Agabiti-Rosei, Enrico; More

Journal of Hypertension. 38(5):799-812, May 2020.

Reply

Völz, Sebastian; Spaak, Jonas; Rundqvist, Bengt; More

Journal of Hypertension. 37(2):449-451, February 2019.

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: ESC/ESH Task Force for the Management of Arterial Hypertension

Williams, Bryan; Mancia, Giuseppe; Spiering, Wilko; More

Journal of Hypertension. 36(12):2284-2309, December 2018.

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

Williams, Bryan; Mancia, Giuseppe; Spiering, Wilko; More

Journal of Hypertension. 36(10):1953-2041, October 2018.

Reply

Iacobaeus, Charlotte; Andolf, Ellika; Thorsell, Malin; More

Journal of Hypertension. 36(8):1770-1771, August 2018.

Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis

Persu, Alexandre; Gordin, Daniel; Jacobs, Lotte; More

Journal of Hypertension. 36(2):221-229, February 2018.

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension*

Perrone-Filardi, Pasquale; Coca, Antonio; Galderisi, Maurizio; More

Journal of Hypertension. 35(9):1727-1741, September 2017.

Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study

Omboni, Stefano; Aristizabal, Dagnovar; De la Sierra, Alejandro; More

Journal of Hypertension. 34(11):2187-2198, November 2016.

PS 14-65 THE EFFECTS OF BAROREFLEX ACTIVATION THERAPY ON BLOOD PRESSURE AND SYMPATHETIC FUNCTION IN PATIENTS WITH REFRACTORY HYPERTENSION – THE RATIONALE AND DESIGN OF THE NORDIC BAT STUDY

Kjeldsen, Sverre E; Elmula, Fadl Elmula M. Fadl; Gordin, Daniel; More

Journal of Hypertension. 34:e451-e452, September 2016.

Hyperresponders vs. nonresponder patients after renal denervation: do they differ?

Persu, Alexandre; Azizi, Michel; Jin, Yu; More

Journal of Hypertension. 32(12):2422-2427, December 2014.

B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

Hallberg, Pär; Lind, Lars; Michaëlsson, Karl; More

Journal of Hypertension. 21(3):621-624, March 2003.

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

Hallberg, Pär; Karlsson, Julia; Kurland, Lisa; More

Journal of Hypertension. 20(10):2089-2093, October 2002.

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

Kurland, Lisa; Melhus, Håkan; Karlsson, Julia; More

Journal of Hypertension. 20(4):657-663, April 2002.

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

Kurland, Lisa; Melhus, Håkan; Karlsson, Julia; More

Journal of Hypertension. 19(10):1783-1787, October 2001.

Show: